AndroGel Buyers Can't Use FTC Case Against AbbVie, Besins
Drug wholesalers suing AbbVie and Besins for delaying generic Androgel from hitting the market can't stop the pharmaceutical companies from relitigating issues that the buyers said were already decided in a...To view the full article, register now.
Already a subscriber? Click here to view full article